Glen Eagle Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.7K Hold
440
﹤0.01% 500
2025
Q1
$32.3K Sell
440
-141
-24% -$10.4K 0.01% 480
2024
Q4
$38.1K Hold
581
0.01% 460
2024
Q3
$45.3K Buy
581
+7
+1% +$546 0.01% 436
2024
Q2
$44.8K Buy
574
+307
+115% +$24K 0.01% 420
2024
Q1
$18.1K Hold
267
﹤0.01% 558
2023
Q4
$18K Sell
267
-50
-16% -$3.37K ﹤0.01% 547
2023
Q3
$21.5K Buy
317
+21
+7% +$1.42K 0.01% 517
2023
Q2
$21.1K Buy
296
+1
+0.3% +$71 ﹤0.01% 523
2023
Q1
$20.5K Sell
295
-12
-4% -$833 0.01% 508
2022
Q4
$20.8K Buy
307
+177
+136% +$12K 0.01% 491
2022
Q3
$7.13K Buy
130
+47
+57% +$2.58K ﹤0.01% 647
2022
Q2
$5.48K Sell
83
-15
-15% -$991 ﹤0.01% 704
2022
Q1
$6.5K Hold
98
﹤0.01% 686
2021
Q4
$5.71K Sell
98
-455
-82% -$26.5K ﹤0.01% 695
2021
Q3
$33.2K Hold
553
0.01% 450
2021
Q2
$33.1K Hold
553
0.01% 452
2021
Q1
$27.5K Buy
553
+270
+95% +$13.4K 0.01% 455
2020
Q4
$14.1K Buy
283
+33
+13% +$1.65K 0.01% 563
2020
Q3
$13.7K Buy
250
+50
+25% +$2.74K 0.01% 531
2020
Q2
$10.6K Hold
200
0.01% 555
2020
Q1
$8.93K Hold
200
0.01% 532
2019
Q4
$9.97K Hold
200
0.01% 585
2019
Q3
$8.91K Hold
200
0.01% 529
2019
Q2
$8.26K Sell
200
-650
-76% -$26.8K 0.01% 534
2019
Q1
$34.4K Hold
850
0.03% 313
2018
Q4
$32.3K Hold
850
0.03% 293
2018
Q3
$33.6K Hold
850
0.02% 308
2018
Q2
$29.8K Hold
850
0.02% 310
2018
Q1
$29.7K Hold
850
0.02% 301
2017
Q4
$29.5K Hold
850
0.03% 294
2017
Q3
$28.8K Sell
850
-150
-15% -$5.08K 0.03% 291
2017
Q2
$34.1K Hold
1,000
0.03% 248
2017
Q1
$31.1K Hold
1,000
0.03% 246
2016
Q4
$27.3K Buy
+1,000
New +$27.3K 0.02% 257